Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 61 AL 75

[Research progress in pharmacological effects of Uncaria Hook on Alzheimer disease models]

Liu L, Zhao YH, Zeng CQ, Zeng Y.

Yao Xue Xue Bao. 2016 Apr;51(4):536-42.

Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients

Gauthier S, Rosa-Neto P, Kass JS.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):615-8. doi: 10.1212/CON.0000000000000306.

[Alzheimer patients: another approach]

Marrocco J, Hudon J.

Krankenpfl Soins Infirm. 2016;109(3):74-5, 90-1.

Are cognitive interventions effective in Alzheimer's disease? A controlled meta-analysis of the effects of bias

Oltra-Cucarella J, Pérez-Elvira R, Espert R, Sohn McCormick A.

Neuropsychology. 2016 Jul;30(5):631-52. doi: 10.1037/neu0000283. Epub 2016 Apr 7.

Rhodiola rosea L. and Alzheimer's Disease: From Farm to Pharmacy

Nabavi SF, Braidy N, Orhan IE, Badiee A, Daglia M, Nabavi SM.

Phytother Res. 2016 Apr;30(4):532-9. doi: 10.1002/ptr.5569. Epub 2016 Jan 11.

sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease

Warrier S, Marimuthu R, Sekhar S, Bhuvanalakshmi G, Arfuso F, Das AK, Bhonde R, Martins R, Dharmarajan A.

Int J Biochem Cell Biol. 2016 Jun;75:104-11. doi: 10.1016/j.biocel.2016.04.002. Epub 2016 Apr 7.

Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease

Prati F, Cavalli A, Bolognesi ML.

Molecules. 2016 Apr 8;21(4):466. doi: 10.3390/molecules21040466.

DYRK1A inhibition as potential treatment for Alzheimer's disease

Stotani S, Giordanetto F, Medda F.

Future Med Chem. 2016 Apr;8(6):681-96. doi: 10.4155/fmc-2016-0013. Epub 2016 Apr 13.

Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics

Rosini M, Simoni E, Caporaso R, Minarini A.

Future Med Chem. 2016 Apr;8(6):697-711. doi: 10.4155/fmc-2016-0003. Epub 2016 Apr 15.

Vaccination to Alzheimer Disease. Is it a Promising Tool or a Blind Way?

Pohanka M.

Curr Med Chem. 2016;23(14):1432-41. doi: 10.2174/0929867323666160418114733.

Alzheimer's therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies

Ohno M.

Brain Res Bull. 2016 Sep;126(Pt 2):183-198. doi: 10.1016/j.brainresbull.2016.04.007. Epub 2016 Apr 16.

Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism

Hroudová J, Singh N, Fišar Z, Ghosh KK.

Eur J Med Chem. 2016 Oct 4;121:774-784. doi: 10.1016/j.ejmech.2016.03.084. Epub 2016 Mar 30.

Targeting microglia for the treatment of Alzheimer's Disease

Wes PD, Sayed FA, Bard F, Gan L.

Glia. 2016 Oct;64(10):1710-32. doi: 10.1002/glia.22988. Epub 2016 Apr 21.

Association of the MIND diet with cognition and risk of Alzheimer's disease

Koch M, Jensen MK.

Curr Opin Lipidol. 2016 Jun;27(3):303-4. doi: 10.1097/MOL.0000000000000304.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias